Luye Pharma USA Ltd. Email Format
Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees
Luye Pharma USA Ltd. operates as a professional pharmaceutical company focused on innovative research and development along with comprehensive clinical and regulatory strategy. The Princeton, New Jersey unit, founded in 2012, serves as Luye's U.S. clinical and regulatory arm and functions as a private equity hub for the United States. The broader Luye Pharma LTD network includes R&D centers in China, the United States, and Europe and overseas offices in Hong Kong, Singapore, and Malaysia, employing roughly 4,000 people globally. Situated in the pharmaceutical manufacturing sector, Luye Pharma USA contributes to Luye's U.S. clinical and regulatory activities. A recent development in the group activity is the March 2024 launch of Zepzelca for small cell lung cancer in Hong Kong and Macao.